# HHLR ADVISORS, LTD.

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1762304. Source: https://holderbook.com/funds/1762304-hhlr-advisors-ltd/

- Reported value: $832.1M
- Positions: 35
- Weight of the ten largest: 85.7%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | [LEGN](https://holderbook.com/stocks/LEGN/) | $172.8M | 5,984,550 | 20.8% | 25 |
| FUTU HLDGS LTD | [FUTU](https://holderbook.com/stocks/FUTU/) | $165.8M | 1,768,283 | 19.9% | 9 |
| ARRIVENT BIOPHARMA INC | [AVBP](https://holderbook.com/stocks/AVBP/) | $136.5M | 3,929,117 | 16.4% | 10 |
| MARVELL TECHNOLOGY INC | [MRVL](https://holderbook.com/stocks/MRVL/) | $48.5M | 162,933 | 5.8% | 2 |
| VIPSHOP HLDGS LTD | [VIPS](https://holderbook.com/stocks/VIPS/) | $46.0M | 3,470,400 | 5.5% | 2 |
| PDD HOLDINGS INC | [PDD](https://holderbook.com/stocks/PDD/) | $38.1M | 500,000 | 4.6% | 17 |
| KE HLDGS INC | [BEKE](https://holderbook.com/stocks/BEKE/) | $32.2M | 2,218,377 | 3.9% | 24 |
| CYTEK BIOSCIENCES INC | [CTKB](https://holderbook.com/stocks/CTKB/) | $29.5M | 6,657,030 | 3.5% | 20 |
| ALAMAR BIOSCIENCES INC | [ALMR](https://holderbook.com/stocks/ALMR/) | $25.9M | 956,462 | 3.1% | 1 |
| ALIBABA GROUP HLDG LTD | [BABA](https://holderbook.com/stocks/BABA/) | $17.7M | 183,934 | 2.1% | 17 |
| ODYSSEY THERAPEUTICS INC | [ODTX](https://holderbook.com/stocks/ODTX/) | $15.6M | 831,656 | 1.9% | 1 |
| YATSEN HLDG LTD | [YSG](https://holderbook.com/stocks/YSG/) | $15.5M | 4,885,873 | 1.9% | 10 |
| NOVABRIDGE BIOSCIENCES | [NBP](https://holderbook.com/stocks/NBP/) | $11.7M | 5,980,568 | 1.4% | 24 |
| CONTINEUM THERAPEUTICS INC | [CTNM](https://holderbook.com/stocks/CTNM/) | $11.0M | 669,337 | 1.3% | 9 |
| MAZE THERAPEUTICS INC | [MAZE](https://holderbook.com/stocks/MAZE/) | $10.9M | 366,028 | 1.3% | 6 |
| AGORA INC | [API](https://holderbook.com/stocks/API/) | $8.4M | 2,098,553 | 1.0% | 7 |
| TAIWAN SEMICONDUCTOR MANUFAC | [TSM](https://holderbook.com/stocks/TSM/) | $7.4M | 15,510 | 0.9% | 3 |
| SAGIMET BIOSCIENCES INC | [SGMT](https://holderbook.com/stocks/SGMT/) | $5.6M | 724,800 | 0.7% | 12 |
| NETEASE COM INC | [NTES](https://holderbook.com/stocks/NTES/) | $4.5M | 34,999 | 0.5% | 1 |
| GE AEROSPACE | [GE](https://holderbook.com/stocks/GE/) | $3.8M | 10,043 | 0.5% | 10 |
| LUMENTUM HLDGS INC | [LITE](https://holderbook.com/stocks/LITE/) | $2.8M | 3,300 | 0.3% | 2 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $2.8M | 14,054 | 0.3% | 2 |
| TUYA INC | [TUYA](https://holderbook.com/stocks/TUYA/) | $2.8M | 1,564,400 | 0.3% | 22 |
| CORNING INC | [GLW](https://holderbook.com/stocks/GLW/) | $2.6M | 10,266 | 0.3% | 2 |
| COHERENT CORP | [COHR](https://holderbook.com/stocks/COHR/) | $2.5M | 6,417 | 0.3% | 2 |
| WEBULL CORP | [BULL](https://holderbook.com/stocks/BULL/) | $2.0M | 309,857 | 0.2% | 5 |
| INTEL CORP | [INTC](https://holderbook.com/stocks/INTC/) | $2.0M | 14,300 | 0.2% | 2 |
| PACIFIC BIOSCIENCES CALIF IN | [PACB](https://holderbook.com/stocks/PACB/) | $1.5M | 918,892 | 0.2% | 12 |
| TEXAS INSTRS INC | [TXN](https://holderbook.com/stocks/TXN/) | $1.4M | 4,800 | 0.2% | 1 |
| MOGU INC | [MOGU](https://holderbook.com/stocks/MOGU/) | $1.4M | 847,510 | 0.2% | 18 |
| GOSSAMER BIO INC | [GOSS](https://holderbook.com/stocks/GOSS/) | $818.7K | 4,974,041 | 0.1% | 30 |
| EQUINOX GOLD CORP | [EQX](https://holderbook.com/stocks/EQX/) | $782.5K | 80,500 | 0.1% | 4 |
| ZOOM COMMUNICATIONS INC | [ZM](https://holderbook.com/stocks/ZM/) | $777.7K | 9,010 | 0.1% | 1 |
| ALIGOS THERAPEUTICS INC | [ALGS](https://holderbook.com/stocks/ALGS/) | $439.9K | 76,247 | 0.1% | 8 |
| RIDGETECH INC | - | $204 | 136 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | -6.2% | +14.8% | -21.0% | 98% |
| Q1 2026 | -11.5% | -4.6% | -6.9% | 100% |
| Q4 2025 | -16.4% | +2.4% | -18.7% | 100% |
| Q3 2025 | +23.8% | +7.8% | +16.0% | 100% |
| Q2 2025 | -0.9% | +10.5% | -11.3% | 98% |
| Q1 2025 | +25.3% | -4.6% | +29.9% | 100% |
| Q4 2024 | -16.6% | +2.1% | -18.8% | 100% |
| Q3 2024 | +23.6% | +5.4% | +18.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $832.1M | 35 |
| Q1 2026 | $1.7B | 38 |
| Q4 2025 | $3.1B | 33 |
| Q3 2025 | $4.1B | 33 |
| Q2 2025 | $3.1B | 36 |
| Q1 2025 | $3.5B | 49 |
| Q4 2024 | $2.9B | 45 |
| Q3 2024 | $4.6B | 48 |
| Q2 2024 | $4.1B | 78 |
| Q1 2024 | $4.6B | 63 |
| Q4 2023 | $5.0B | 49 |
| Q3 2023 | $4.5B | 60 |